title: ABO-incompatible kidney transplantation with donor-specific skin graft.
abstract: From November 3, 1975, to May 31, 1989, 711 (548 living-related and 163 cadavers) kidney transplantations were performed in our centers. In the final 2 years, 15 ABO-incompatible living related kidney transplantations were performed. In 4 cases, the recipient's blood groups was O and the donor's A1. In 3 cases the blood group of the recipient was A1 and the donor's AB, two patients were B with the donors A1 and the other 2 were O with donors B. The other 3 recipients group was B and the donors' were AB. The donors' and recipients' HLA-AB typing showed one haplotype matching in 12 and two haplotypes matching in 3 patients. The donors were mothers in 7 cases, sibling in 5, and father in 3 cases. At least 3 weeks before the renal transplantation, donor-specific skin grafts and subsequently splenectomy were performed on 9 recipients, but on 6 recipients without splenectomy. Following the skin graft, cross-match was done starting from the 15th day and then continued every week. The immunosuppression, which consisted of triple drugs (0.5 mg/kg prednisolone, 2 mg/kg cyclosporin-A and 2 mg/kg azathioprine) was followed by skin graft. Renal transplantation was performed according to cross-match and skin graft results, and all recipients prior to surgery received at least two sessions of plasmapheresis. Regular dose of immunosuppression that included triple drugs were used after the kidney transplantation and then Orthoclone OKT-3 and plasmapheresis were applied during the rejection episodes without bolus therapy. All patients were followed for 5 to 24 months (ave. 14,13 months).(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Turkish Transplantation and Burn Foundation Hospital, Ankara.
authors.forename: M
authors.initials: M
authors.lastname: Haberal
authors.forename: H
authors.initials: H
authors.lastname: Gülay
authors.forename: G
authors.initials: G
authors.lastname: Arslan
authors.forename: S
authors.initials: S
authors.lastname: Sert
authors.forename: S
authors.initials: S
authors.lastname: Altunkan
authors.forename: N
authors.initials: N
authors.lastname: Bilgin
mesh_terms: D000017:ABO Blood-Group System / Q000276:immunology*; D000293:Adolescent; D000328:Adult; D000368:Aged; D001787:Blood Group Incompatibility / Q000276:immunology; D005260:Female; D006082:Graft Enhancement, Immunologic; D006084:Graft Rejection; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology* / Q000379:methods; D008297:Male; D008875:Middle Aged; D016038:Skin Transplantation / Q000276:immunology*; D013156:Splenectomy
chemical_list: D000017:ABO Blood-Group System